Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.61 |
| ▸ | ACHE | P22303 | 7/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.47 |
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10512790 | 0.87 | EPHX1 (0.68) | EPHX1ACHECASP2 | |
| SCHEMBL7651845 | 0.84 | EPHX1 (0.63) | EPHX1ACHECASP2 | |
| SCHEMBL20503322 | 0.84 | EPHX1 (0.63) | EPHX1ACHECASP2 | |
| SCHEMBL7648051 | 0.84 | EPHX1 (0.63) | EPHX1ACHECASP2 | |
| SCHEMBL7649029 | 0.84 | EPHX1 (0.63) | EPHX1ACHECASP2 | |
| SCHEMBL7653206 | 0.84 | EPHX1 (0.63) | EPHX1ACHECASP2 | |
| SCHEMBL28990518 | 0.81 | EPHX1 (0.66) | EPHX1ACHECASP2 | |
| SCHEMBL1357151 | 0.81 | EPHX1 (0.66) | EPHX1ACHECASP2 | |
| SCHEMBL25375589 | 0.80 | CASP2 (0.59) | EPHX1CASP2 | |
| SCHEMBL6420176 | 0.79 | EPHX1 (0.68) | EPHX1ACHECASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391744-A1 | TETRAHYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) | 2023-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391744-A1 | TETRAHYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | CYP11B2, HTT, REN | EPHX1 1071/4885ACHE 475/4885CASP2 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.